• Kevin Keim, PhD, has been appointedchief development officer at INC Research (Raleigh, North Carolina), a contract research organization. Keim will also take the helm of INC’s new outreach program to the Japanese pharma and biotech business community. Most recently, Keim served as president/CEO and board member of Vela Pharmaceuticals, as well as founder and managing principal of K.L. Keim Consulting Group.

• Austin Noll has been named new president/CEO ofNeoGuide Systems (Los Gatos, California), a developer of the NeoGuide Endoscopy System. Previously, Noll held leadership positions at Medtronic over a 13-year period. Amir Belson, MD, company founder and inventor of the company’s technology, will remain full-time with NeoGuide as a board member and chief technology officer.

• Paul Castillo, MD, has been named chief medical officer of Veridgm (Los Angeles), a telemedicine and network communication company. Castillo will oversee the implementation of Veridigm’s telemedicine technology and will serve as the company’s primary conduit to the professional medical community. He previously was a clinical technology consultant to the U.S. Congress and medical director for a Rand-based venture to build software used to manage chronic diseases.

• Theresa Bachhuber, RN, has been named hospice director for the VITAS Innovative Hospice Care (Middlebury, Connecticut), which serves patients and families living in the Eastern Connecticut area and is one of three VITAS programs in Connecticut. Prior to joining VITAS, Bachhuber was a home care administrator at Bristol Hospital.